Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
J Atheroscler Thromb ; 26(11): 979-988, 2019 Nov 01.
Article in English | MEDLINE | ID: mdl-30890680

ABSTRACT

AIM: The purpose of this study was to compare two homogeneous assays of low-density lipoprotein-cholesterol (LDL-C) with a modified beta quantification reference measurement for LDL-C (BQ-LDL), fractions of chylomicron (CM), very low-density lipoprotein (VLDL) and intermediate-density lipoprotein (IDL) by quantitative ultracentrifugation in patients with hypertriglyceridemia. METHODS: Two homogeneous LDL-C assays (LDL-C(K), Kyowa Medex and LDL-C(S), Sekisui Medical) were used to measure 198 samples of fresh anonymized leftover sera with hypertriglyceridemia (≥ 150 mg/dL). Of these, 32 samples with discrepant LDL-C levels or hypertriglyceridemia (≥ 400 mg/dL) were used for further analysis. Quantitative ultracentrifugation was used to separate samples. RESULTS: The two homogeneous LDL-C assays had a strong correlation with each other for the samples from 198 patients with hypertriglyceridemia. LDL-C(K) and LDL-C(S) in 32 selected samples were strongly correlated with BQ-LDL. In both homogeneous assays, cholesterol in the CM and VLDL fractions was measured as part of the LDL-C. A weak correlation was found between cholesterol in the VLDL fraction and LDL-C using the two homogeneous assays, but no correlation was found with cholesterol in the CM fraction. Cholesterol in the IDL fraction was also measured as part of the LDL-C in both assays. CONCLUSION: Both homogeneous assays partially detected cholesterol in the chylomicron and VLDL fractions, but LDL-C measured by both homogeneous assays correlated with BQ-LDL.


Subject(s)
Biological Assay/methods , Biomarkers/blood , Cholesterol, LDL/blood , Hypertriglyceridemia/diagnosis , Ultracentrifugation/methods , Adult , Aged , Aged, 80 and over , Chylomicrons/blood , Female , Follow-Up Studies , Humans , Hypertriglyceridemia/blood , Male , Middle Aged , Prognosis , Triglycerides/blood , Young Adult
2.
Rinsho Byori ; 62(10): 931-6, 2014 Oct.
Article in Japanese | MEDLINE | ID: mdl-27526537

ABSTRACT

Procalcitonin (PCT) is a frequently used marker for bacterial sepsis. The present study was aimed to assess the usefulness of PCT measurement in patient with sepsis. We studied the relationship between serum PCT level and blood culture in clinical 209 cases admitted from January 2010 through June 2010. We compared PCT level with blood culture results and other clinical data, and diagnosis such as sepsis and systemic inflammatory response syndrome (SIRS) were obtained from the medical records. In the case of patients with positive blood cultures and PCT < 0.5 ng/mL, the false- positive blood culture was suspected. The possibility of bacteremia was high when PCT level was more than 0.5 ng/mL. Patients with PCT ≥ 2 ng/mL had significant correlation with the presence of sepsis. The PCT measurement could be performed and reported rapidly and provided valuable information before availability of culture results. In this study, we found that the PCT would be a useful biomarker for confirming and ruling out sepsis.


Subject(s)
Bacteremia/diagnosis , Calcitonin/blood , Protein Precursors/blood , Sepsis/diagnosis , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Calcitonin Gene-Related Peptide , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Young Adult
3.
Clin Chim Acta ; 415: 250-4, 2013 Jan 16.
Article in English | MEDLINE | ID: mdl-23159841

ABSTRACT

BACKGROUND: Insulin analogs are often used to treat patients with diabetes. We evaluated the cross-reactivities of anti-insulin antibodies in two insulin immunoassay kits (Architect and ECLusys) against recombinant human insulin and insulin analogs, and measured insulin concentrations in the serum of the diabetic patients treated with only insulin lispro. METHODS: Ten-fold dilutions of recombinant human insulins and insulin analogs were measured using Architect and ECLusys kits. The serum samples of 4 type 2 diabetic patients at fasting, and several time points after breakfast (25 kcal/kg) following subcutaneous injection of insulin lispro were measured by Architect, ECLusys and LISPro RIA kit. RESULTS: The ECLusys kit could detect human insulin but not insulin analogs. The Architect kit detected human insulin and insulin analogs with similar recovery ratios. The difference in serum insulin concentrations measured by Architect and ECLusys assays reflected the concentration measured by LISPro insulin kit in the patients. The differences in the AUC between Architect and ECLusys assays were significantly correlated with the AUC for LISPro assay (p<0.01). CONCLUSIONS: By exploiting the different cross-reactivities of anti-insulin antibodies to insulin analogs, it may be possible to measure the endogenous and exogenous insulin concentrations in diabetic patients treated with insulin analogs.


Subject(s)
Antibody Specificity , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/analysis , Insulin Antibodies/immunology , Insulin Lispro/analysis , Insulin/analysis , Aged , Area Under Curve , Blood Glucose/analysis , Cross Reactions , Diabetes Mellitus, Type 2/metabolism , Fasting , Female , Humans , Hypoglycemic Agents/administration & dosage , Immunoassay , Injections, Subcutaneous , Insulin/biosynthesis , Insulin Antibodies/chemistry , Insulin Lispro/administration & dosage , Male , Middle Aged , Recombinant Proteins/administration & dosage , Recombinant Proteins/analysis , Sensitivity and Specificity
4.
Rinsho Byori ; 55(12): 1067-74, 2007 Dec.
Article in Japanese | MEDLINE | ID: mdl-18283858

ABSTRACT

In order to support a faster and more informative clinical practice, we established the criteria for panic (critical) values regarding the blood concentrations of glucose, Na, K, Ca, inorganic phosphate (IP), Hb and number of platelets, and also created a system to report these values directly to the doctors in charge. We initiated this system in September 2003. In order to evaluate the availability of this system, we analyzed the clinical data during a one year period, based on the findings of patients showing panic values, mainly concerning the disease states and the correspondences by the doctors who were directly informed. We also carried out questionnaire surveys about the panic values and the new system for all of the doctors in our hospital (recovery rate: 84.3%). The total number of panic values reported was 113 and the mean percentage of the number of ordered examinations was 0.019%. After the report, 79 cases (69.9%) were examined again or treated, while 34 cases (30.1%) had already been treated or watched carefully at the time of the report. Malignant diseases were the main causes of increased panic values (38 cases), especially in the Na, K and blood glucose of patients. The next disease state, which appeared to demonstrate high rates, was chronic renal failure (16 cases), in the low K, high Ca, and low IP patients. Most of the cases of low Hb were caused from bleeding of the gastro-intestinal tract, with malignancies next. A blood infusion was performed for all of the cases with low Hb except for one. As a result of the questionnaire survey among the staff doctors, we confirmed that this system did indeed work efficiently, and 88% of the doctors who answered the questionnaires, were satisfied with the system. In conclusion, we established a new system, which made it possible for panic values to be directly reported to the doctor in charge and this system was then evaluated for its clinical usefulness.


Subject(s)
Emergencies , Hospital Communication Systems/standards , Laboratories, Hospital/organization & administration , Japan , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...